Narlumosbart

CAT: 0804-HY-P99966-01Size: 1 mgDry Ice: YesHazardous: No

1 / 1

CAT#:0804-HY-P99966-01Size:1 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

Narlumosbart (JMT103) is an IgG4κ antibody targeting receptor activator of nuclear factor-κB ligand (RANKL) [1].

CAS Number

2646587-68-8

UNSPSC

12352203

Target

RANKL/RANK

Type

Inhibitory Antibodies

Related Pathways

NF-κB

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/narlumosbart.html

Purity

97.00

Solubility

10 mM in DMSO

Smiles

[Narlumosbart]

Molecular Weight

(144.886 kDa)

References & Citations

[1]Kaplon H, Crescioli S, Chenoweth A, Visweswaraiah J, Reichert JM. Antibodies to watch in 2023. MAbs. 2023 Jan-Dec;15 (1) :2153410.

Shipping Conditions

Dry Ice

Storage Conditions

Store at -80°C for 2 years

Scientific Category

Inhibitory Antibodies

Clinical Information

Phase 3

Alternative Products

Catalog	Name
MBS5822278	Narlumosbart
GTR18333913	Narlumosbart Antibody
DHA30302	Research Grade Narlumosbart
E55B1011	Narlumosbart (Reference antibody)
ICH5261-10mg	Narlumosbart Biosimilar - Research Grade
GTR18780733-01	(Narlumosbart) Biosimilar Reference Antibody
GTR18696606-01	Narlumosbart Human Monoclonal Antibody
RA0786-01	Narlumosbart (Biosimilar Reference Antibody) (TNFSF11)
A136192	Narlumosbart Biosimilar (Monoclonal, IgG4-kappa)
PX-TA2079-01	Narlumosbart Biosimilar - Anti-ODF mAb - Research Grade